Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Iron Chelation Therapy”

49 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 49 results

Testing effectiveness (Phase 2)Study completedNCT04092205
What this trial is testing

Phase 2a Pilot Study of NBMI Treatment in Patients With Beta Thalassemia Major, Requiring Iron Chelation

Who this might be right for
Beta Thalassemia Major
EmeraMed 13
Not applicableNot Yet RecruitingNCT07660224
What this trial is testing

The Effect of Motivational Interviewing on Treatment Adherence and Self-Efficacy Among Omani Adults With Thalassemia

Who this might be right for
Beta-Thalassemia MajorTransfusion-Dependent Thalassemia
Oman Ministry of Health 45
Not applicableStudy completedNCT01394029
What this trial is testing

Observation of Patients With Transfusional Hemosiderosis Treatment With Deferasirox

Who this might be right for
Transfusional Hemosiderosis
Novartis Pharmaceuticals 120
Testing effectiveness (Phase 2)Study completedNCT02435212
What this trial is testing

Study to Evaluate Treatment Compliance, Efficacy and Safety of an Improved Deferasirox Formulation (Granules) in Pediatric Patients (2-<18 Years Old) With Iron Overload

Who this might be right for
Transfusion-dependent Anemia
Novartis Pharmaceuticals 224
Not applicableUnknownNCT02833493
What this trial is testing

Study of MRI Monitoring in Patients With Aplastic Anemia and Low or Int-1 Risk of MDS Complicated With Iron Overload

Who this might be right for
Aplastic AnemiaDysmyelopoietic SyndromesIron Overload
Peking Union Medical College Hospital 80
Testing effectiveness (Phase 2)Study completedNCT03637556
What this trial is testing

Pilot Study to Assess the Safety, PK and Iron Chelating Activity of DST-0509 (Deferasirox) in Thalassemia Patients Refractory to Chelation

Who this might be right for
Thalassemia Major
DisperSol Technologies, LLC 25
Not applicableUnknownNCT02474420
What this trial is testing

Amlodipine as Adjuvant Treatment to Iron Chelation for Prevention of Cardiac Iron Overload in Thalassemia Patients

Who this might be right for
Beta-ThalassemiaIron Overload
Kevin H.M. Kuo, MD, MSc, FRCPC 60
Testing effectiveness (Phase 2)Study completedNCT00379483
What this trial is testing

Extension Study of Iron Chelation Therapy With Deferasirox in Patients With Transfusional Iron Overload

Who this might be right for
Transfusional Iron Overload
Novartis Pharmaceuticals 66
Testing effectiveness (Phase 2)Ended earlyNCT01604941
What this trial is testing

Pharmacokinetics of SSP-004184 in the Treatment of Chronic Iron Overload Requiring Chelation Therapy

Who this might be right for
Iron Overload Due to Repeated Red Blood Cell Transfusions
Shire 32
Post-approval studies (Phase 4)Study completedNCT03591575
What this trial is testing

Safety and Efficacy of Early Treatment With Deferiprone in Infants and Young Children

Who this might be right for
Beta Thalassemia Major AnemiaIron Overload
Chiesi Canada Corp 64
Not applicableLooking for participantsNCT06781099
What this trial is testing

Feasibility Trial of Extracorporeal Iron Purification in Patients With Myelodysplastic Syndrome or Myelofibrosis

Who this might be right for
Myelodysplastic SyndromeMyelofibrosis
Hospices Civils de Lyon 13
Testing effectiveness (Phase 2)Study completedNCT00901199
What this trial is testing

Combined Chelation Therapy in Patients With Transfusion Dependent Thalassemia and Iron Overload

Who this might be right for
ThalassemiaIron Overload
Elliott Vichinsky 22
Testing effectiveness (Phase 2)Study completedNCT00390858
What this trial is testing

A 4-year Extension Study to Core 1-year Study of Iron Chelation Therapy With Deferasirox in β-thalassemia Major Pediatric Patients With Transfusional Iron Overload.

Who this might be right for
Transfusional Iron Overloadβ-thalassemia MajorPediatric Rare Anemia
Novartis Pharmaceuticals 40
Testing effectiveness (Phase 2)Study completedNCT04269889
What this trial is testing

Treatment of Refractory Diamond-Blackfan Anemia With Eltrombopag

Who this might be right for
Anemia, Diamond-Blackfan
National Heart, Lung, and Blood Institute (NHLBI) 15
Testing effectiveness (Phase 2)Study completedNCT00940602
What this trial is testing

Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study

Who this might be right for
Myelodysplastic Syndromes
Novartis Pharmaceuticals 225
Testing effectiveness (Phase 2)UnknownNCT00907283
What this trial is testing

Ferrochelating Treatment in Patients Affected by Neurodegeneration With Brain Iron Accumulation (NBIA)

Who this might be right for
Neurodegenerative DiseaseIron Overload
Ente Ospedaliero Ospedali Galliera 20
Large-scale testing (Phase 3)Study completedNCT04292314
What this trial is testing

Hydroxy Urea, Omega 3, Nigella Sativa,Honey on Oxidative Stress and Iron Chelation in Pediatric Major Thalassemia

Who this might be right for
Iron OverloadOxidative StressThalassemia Major
Beni-Suef University 350
Testing effectiveness (Phase 2)Ended earlyNCT05111821
What this trial is testing

Iron Chelation in the Prevention of Secondary Degeneration After Stroke

Who this might be right for
Stroke
University Hospital, Bordeaux 11
Testing effectiveness (Phase 2)Study completedNCT00000588
What this trial is testing

Chelation Therapy of Iron Overload With Pyridoxal Isonicotinoyl Hydrazone

Who this might be right for
Anemia (Iron-Loading)Beta-ThalassemiaHematologic Diseases+3 more
Case Western Reserve University 120
Not applicableStudy completedNCT05440487
What this trial is testing

Study to Assess Iron Chelation Therapy in Patients With Chronic Iron Overload

Who this might be right for
Chronic Iron Overload
Novartis Pharmaceuticals 489
Next Page